Developer of immunoassay point-of-care tests will highlight product line expansions at the popular drug and alcohol testing industry conference in Orlando, Fla., May 16-18.
San Diego, CA, May 09, 2017 –(PR.com)– ALFA, the developer and manufacturer of Instant-view® rapid immunoassay point-of-care tests (POCTs), will launch their new product line, Instant-view-PLUS™, at the Drug and Alcohol Testing Industry Association’s (DATIA) annual conference at the Rosen Shingle Creek conference resort in Orlando, Florida, May 16-18, 2017. The product line features ALFA’s highly anticipated Driven Flow™ Technology and will be exhibited at booth #511.
“We’ve worked meticulously on continuous improvements of our testing devices,” says ALFA VP of US Sales, Tim Knowles. “Specifically the development of our newest product line, Instant-view-PLUS™ with Driven Flow™ inside. The groundbreaking improvements our scientists are making to lateral flow test strips will revolutionize the rapid POCTs industry. We are thrilled to be launching Instant-view-PLUS™ and showcasing our cutting-edge technology at DATIA this year.”
Instant-view-PLUS™ Saliva Drug Test is a rapid immunoassay utilizing Driven Flow™ technology. Unlike other saliva drug tests, ALFA’s Instant-view-PLUS™ saliva test provides results within 2 minutes and is available with configurations up to 9 drugs. With an easy-to-use specimen collection tube, ALFA’s new saliva test is a highly anticipated device for drug testing environments.
DATIA’s annual conference is geared toward all professionals involved in the drug and alcohol testing process with more than 25 educational sessions on a variety of topics. DATIA 2017 will provide the ultimate confluence in critical thinking, best practices, and networking within the global drug and alcohol testing industry.
To learn more about Alfa Scientific Designs, Inc. visit https://www.alfascientific.com/
About Alfa Scientific Designs, Inc.: Alfa Scientific Designs, Inc. (ALFA), established in 1996, is a creative leader innovating new products for rapid, point-of-care medical devices. For the past 20 years, ALFA has developed and manufactured rapid tests, all made exclusively in the USA. With more than 50 products that are US FDA 510(k) cleared (for professional and OTC use) and CLIA waived, ALFA also offers a broad range of services including contract product development, technology transfer, OEM services, custom assembly, and private labeling.
In 2016 ALFA added its most significant invention to its broad range of outstanding products and services, Driven Flow™ Technology. ALFA continues to demonstrate innovative leadership with the addition of another invention to its extensive patent portfolio. With a revolutionary design that significantly improves the speed and accuracy of rapid POCTs, Driven Flow™ is a groundbreaking technology that will revolutionize the rapid IVD market.